Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1661011
PUBLISHER: IMARC | PRODUCT CODE: 1661011
Artificial Pancreas Device Systems Market Report by Device Type, Treatment Type, End-User, and Region 2025-2033
PUBLISHED:
PAGES: 142 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global artificial pancreas device systems (APDS) market size reached USD 2,579.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 6,027.2 Million by 2033, exhibiting a growth rate (CAGR) of 9.9% during 2025-2033.
APDS refers to a closed-loop or automated insulin delivery system that manages blood glucose levels by regulating the production of insulin. It consists of a continuous glucose monitor (CGM), a subcutaneous insulin infusion pump and a controller that links the monitor with the pump. It runs a complex algorithm that determines the adequate levels of insulin and time of delivery based on the evaluation of real-time glucose readings. It is primarily used to minimize the risks of extreme fluctuations of glucose levels in the body.
The increasing prevalence of pancreatic cancer, pancreatitis and other chronic ailments is one of the key factors driving the growth of the market. Furthermore, the growing occurrence of diabetes and obesity, due to age-related factors, physical inactivity and unhealthy dietary patterns, is also contributing to the widespread adoption of APDS across the globe. The rising demand for efficient diabetes monitoring and minimally invasive (MI) drug delivery systems is also providing a boost to the market growth. APDS automatically monitors the glucose levels and administers doses of insulin throughout the day in controlled amounts. Various technological innovations, including the development of software-based wireless systems that are integrated with automated controls, are further contributing to the market growth. Moreover, regulatory bodies and governments of various nations are significantly investing in research and development (R&D) for the improvement of healthcare infrastructure across the globe. For instance, the Food and Drug Association (US FDA) in the United States is approving an increasing number of new and innovative products, which is creating a positive outlook for the market in the country.
Key Market Segmentation:
Breakup by Device Type:
- Threshold Suspend Device Systems
- Control-to-Range Systems
- Control-to-Target Systems
Breakup by Treatment Type:
- Bi-hormonal
- Insulin Only
- Hybrid
Breakup by End-User:
- Hospitals
- Medical Centres
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Beta Bionics Inc., Bigfoot Biomedical Inc., Dexcom Inc., Inreda Diabetic B.V., Insulet Corporation, Johnson & Johnson, Medtronic Inc., F. Hoffmann-La Roche Ltd, Tandem Diabetes Care Inc., etc.
Key Questions Answered in This Report:
- How has the global artificial pancreas device systems market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global artificial pancreas device systems market?
- What is the breakup of the market based on the device type?
- What is the breakup of the market based on the treatment type?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global artificial pancreas device systems market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112025A1918
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Artificial Pancreas Device Systems Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Device Type
- 6.1 Threshold Suspend Device Systems
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Control-to-Range Systems
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Control-to-Target Systems
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Treatment Type
- 7.1 Bi-hormonal
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Insulin Only
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Hybrid
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by End-User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Medical Centres
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Indicators
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Beta Bionics Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Bigfoot Biomedical Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Dexcom Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Inreda Diabetic B.V.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.5 Insulet Corporation
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Johnson & Johnson
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Medtronic Inc.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 F. Hoffmann-La Roche Ltd
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.9 Tandem Diabetes Care Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.1 Beta Bionics Inc.
Product Code: SR112025A1918
List of Figures
- Figure 1: Global: Artificial Pancreas Device Systems Market: Major Drivers and Challenges
- Figure 2: Global: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019-2024
- Figure 3: Global: Artificial Pancreas Device Systems Market: Breakup by Device Type (in %), 2024
- Figure 4: Global: Artificial Pancreas Device Systems Market: Breakup by Treatment Type (in %), 2024
- Figure 5: Global: Artificial Pancreas Device Systems Market: Breakup by End-User (in %), 2024
- Figure 6: Global: Artificial Pancreas Device Systems Market: Breakup by Region (in %), 2024
- Figure 7: Global: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 8: Global: Artificial Pancreas Device Systems (Threshold Suspend Device Systems) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 9: Global: Artificial Pancreas Device Systems (Threshold Suspend Device Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 10: Global: Artificial Pancreas Device Systems (Control-to-Range Systems) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: Artificial Pancreas Device Systems (Control-to-Range Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: Artificial Pancreas Device Systems (Control-to-Target Systems) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: Artificial Pancreas Device Systems (Control-to-Target Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: Artificial Pancreas Device Systems (Bi-hormonal) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: Artificial Pancreas Device Systems (Bi-hormonal) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: Artificial Pancreas Device Systems (Insulin Only) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: Artificial Pancreas Device Systems (Insulin Only) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: Artificial Pancreas Device Systems (Hybrid) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: Artificial Pancreas Device Systems (Hybrid) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: Artificial Pancreas Device Systems (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: Artificial Pancreas Device Systems (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: Global: Artificial Pancreas Device Systems (Medical Centres) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: Global: Artificial Pancreas Device Systems (Medical Centres) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: Global: Artificial Pancreas Device Systems (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: Global: Artificial Pancreas Device Systems (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: North America: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: North America: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: United States: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: United States: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: Canada: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: Canada: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: Asia Pacific: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: Asia Pacific: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: China: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: China: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: Japan: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: Japan: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: India: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: India: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: South Korea: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: South Korea: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: Australia: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: Australia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: Indonesia: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: Indonesia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: Europe: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: Europe: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: Germany: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: Germany: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: France: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: France: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: United Kingdom: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: United Kingdom: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: Italy: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: Italy: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: Spain: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: Spain: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: Russia: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: Russia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: Latin America: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: Latin America: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: Brazil: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: Brazil: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Mexico: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Mexico: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 71: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 72: Middle East and Africa: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
- Figure 73: Middle East and Africa: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 74: Global: Artificial Pancreas Device Systems Industry: SWOT Analysis
- Figure 75: Global: Artificial Pancreas Device Systems Industry: Value Chain Analysis
- Figure 76: Global: Artificial Pancreas Device Systems Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Artificial Pancreas Device Systems Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Device Type (in Million USD), 2025-2033
- Table 3: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
- Table 4: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by End-User (in Million USD), 2025-2033
- Table 5: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 6: Global: Artificial Pancreas Device Systems Market: Competitive Structure
- Table 7: Global: Artificial Pancreas Device Systems Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.